4th Quarter - Report
BROWNSTEIN HYATT FARBER SCHRECK, LLP for PFIZER INC
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Client
Income
$10,000
Expenses
—
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 4th Quarter - Report (this page) | Jan 20, 2016 | $10,000 | Replaced |
| 4th Quarter - Amendment | Apr 17, 2017 | $10,000 | Yes |
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Labor Issues/Antitrust/Workplace LBR
Antitrust issues associated with proposed merger between Pfizer and Allergan
| Lobbyist | Covered position, as disclosed |
|---|---|
| ALEXANDER DAHL | — |
| MAKAN DELAHIM | — |
| MARC LAMPKIN | — |
| WILLIAM MOSCHELLA | — |
| NEIL F QUINTER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.